Evidence map›Paper›PMID 21282638›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter.

Brent J Thompson, Tammy Jessen, L K Henry, Julie R Field, Karen L Gamble, Paul J Gresch, Ana M Carneiro, Rebecca E Horton, Peter J Chisnell, Yekaterina Belova and 3 more

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Inflammation-Induced Histamine Impairs the Capacity of Escitalopram to Increase Hippocampal Extracellular Serotonin.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. The SSRI citalopram affects fetal thalamic axon responsiveness to netrin-1 in vitro independently of SERT antagonism.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Brent J ThompsonDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Tammy Jessen
L K Henry
Julie R Field
Karen L Gamble
Paul J Gresch
Ana M Carneiro
Rebecca E Horton
Peter J Chisnell
Yekaterina Belova
Douglas G McMahon
Lynette C Daws
Randy D Blakely
Vanderbilt University · USThe University of Texas Health Science Center at San Antonio · USUniversity of North Dakota · US

Funding

Project 6 Interactions of Serotonin and Circadian Signaling NetworksP50MH078028 · NIMH · VANDERBILT UNIVERSITY · PI SNODDY, JAY R · 2007 to 2011
$9.8M
REGULATION OF SEROTONIN TRANSPORTERSR01DA007390 · NIDA · VANDERBILT UNIVERSITY · PI BLAKELY, RANDY D. · 1991 to 2010
$3.9M
NIDA NIH HHS DA7390NIDA NIH HHS R01 DA007390NIMH NIH HHS MH078028NIMH NIH HHS P50 MH078028
6 · The paper itself

Abstract

Serotonin [i.e., 5-hydroxytryptamine (5-HT)]-targeted antidepressants are in wide use for the treatment of mood disorders, although many patients do not show a response or experience unpleasant side effects. Psychostimulants, such as cocaine and 3,4-methylenedioxymethamphetamine (i.e., "ecstasy"), also impact 5-HT signaling. To help dissect the contribution of 5-HT signaling to the actions of these and other agents, we developed transgenic mice in which high-affinity recognition of multiple antidepressants and cocaine is eliminated. Our animals possess a modified copy of the 5-HT transporter (i.e., SERT, slc6a4) that bears a single amino acid substitution, I172M, proximal to the 5-HT binding site. Although the M172 substitution does not impact the recognition of 5-HT, this mutation disrupts high-affinity binding of many competitive antagonists in transfected cells. Here, we demonstrate that, in M172 knock-in mice, basal SERT protein levels, 5-HT transport rates, and 5-HT levels are normal. However, SERT M172 mice display a substantial loss of sensitivity to the selective 5-HT reuptake inhibitors fluoxetine and citalopram, as well as to cocaine. Through a series of biochemical, electrophysiological, and behavioral assays, we demonstrate the unique properties of this model and establish directly that SERT is the sole protein responsible for selective 5-HT reuptake inhibitor-mediated alterations in 5-HT clearance, in 5-HT1A autoreceptor modulation of raphe neuron firing, and in behaviors used to predict the utility of antidepressants.

Indexed as

AnimalsAntidepressive AgentsBehavior, AnimalCocaineGene Knock-In TechniquesIn Vitro TechniquesKineticsMiceMice, TransgenicPresynaptic TerminalsRaphe NucleiSelective Serotonin Reuptake InhibitorsSerotoninSerotonin Plasma Membrane Transport ProteinsSynaptosomesAntidepressive AgentsCocaineSelective Serotonin Reuptake InhibitorsSerotoninSerotonin Plasma Membrane Transport Proteins

Identifiers

PMID21282638
PMCPMC3048100
OpenAlexW2131849270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.